"Consumers and health care professionals will soon find updated labeling for extended-release and long-acting opioid pain relievers to help ensure their safe and appropriate use.
In addition to requiring new labeling on these prescript"...
Soma Compound Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Soma Compound (carisoprodol and aspirin) is used, along with rest and physical therapy, to treat injuries and other painful muscular conditions. Carisoprodol is a muscle relaxant and aspirin is a salicylate, which is used to reduce pain, inflammation, and fever. This medication is available in generic form. Common side effects include nausea, vomiting, constipation, lightheadedness, dizziness, drowsiness, stomach upset, headache, or flushing.
The recommended dose of Soma Compound is 1 or 2 tablets, four times daily in adults. One tablet contains 200 mg carisoprodol and 325 mg of aspirin. The recommended maximum duration of use is up to two or three weeks. Soma Compound may interact with antidepressants, alcohol, antihistamines, sedatives, other pain relievers, anxiety medicines, other muscle relaxants, anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), or other salicylates. Tell your doctor all medications and supplements you use. Soma Compound is not recommended for use during pregnancy. It may harm a fetus. Infants born to mothers who have used this medication may have withdrawal symptoms such as irritability, abnormal/persistent crying, vomiting, or diarrhea. Tell your doctor if you notice symptoms in your newborn. This drug may pass into breast milk and could have undesirable effects on a nursing infant. Breastfeeding is not recommended while using this drug. Withdrawal symptoms may occur if you suddenly stop taking this medication.
Our Soma Compound (carisoprodol and aspirin) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Soma Compound in Detail - Patient Information: Side Effects
If you experience any of the following serious side effects, stop taking aspirin and carisoprodol and seek emergency medical attention or contact your doctor immediately:
- an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
- paralysis (loss of feeling) or extreme weakness;
- vision loss;
- agitation or tremor;
- red, black, or bloody stools; or
- bloody vomit.
Other, less serious side effects may be more likely to occur. Continue to take aspirin and carisoprodol and talk to your doctor if you experience
- drowsiness or dizziness;
- blurred vision;
- faint ringing in the ears; or
- nausea or diarrhea.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Soma Compound (Carisoprodol and Aspirin) »
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Soma Compound FDA Prescribing Information: Side Effects
To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-800-526-3840 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
The following adverse reactions which have occurred with the administration of the individual products alone may also occur with the use of Soma Compound (carisoprodol and aspirin) . The following events have been reported during post-approval individual use of carisoprodol and aspirin. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Carisoprodol: The following events have been reported during post-approval use of carisoprodol. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Tachycardia, postural hypotension, and facial flushing (see OVERDOSAGE).
Central Nervous System
Aspirin: The most common adverse reactions associated with the use of aspirin have been gastrointestinal, including abdominal pain, anorexia, nausea, vomiting, gastritis, and occult bleeding (see WARNINGS, Serious Gastrointestinal Adverse Reactions and PRECAUTIONS, Gastrointestinal Adverse Reactions). Other adverse reactions associated with the use of aspirin include elevated liver enzymes, rash, pruritus, purpura, intracranial hemorrhage, interstitial nephritis, acute renal failure, and tinnitus. Tinnitus may be a symptom of high serum salicylate levels (see OVERDOSAGE).
Drug Abuse And Dependence
Carisoprodol is not a controlled substance (see WARNINGS).
Discontinuation of carisoprodol in animals or in humans after chronic administration can produce withdrawal signs, and there are published case reports of human carisoprodol dependence.
In vitro studies demonstrate that carisoprodol elicits barbiturate-like effects. Animal behavioral studies indicate that carisoprodol produces rewarding effects. Monkeys self administer carisoprodol. Drug discrimination studies using rats indicate that carisoprodol has positive reinforcing and discriminating effects similar to barbital, meprobamate, and chlordiazepoxide.
Read the entire FDA prescribing information for Soma Compound (Carisoprodol and Aspirin) »
Additional Soma Compound Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.